Industry and Geographic Information (Tables)

3 Months Ended

Mar. 31, 2022

Industry And Geographic Information [Abstract]

Sales to Individual Customers in Excess of 10% of Total Revenues

The Company had sales to individual customers in excess of 10% of total revenues, as follows:

	Three Months Ended March 31,
	2022		2021
Customer:
A	38	%	—	%
B	14	%	22	%
C	8	%	12	%
Total:	60	%	34	%

Net Revenues by Product Category

Consolidated total revenues by product category for the three months ended March 31, 2022 and 2021 were as follows (in thousands):

	Three Months Ended March 31,
	2022		2021
Rapid Immunoassay	$	892,810	$	237,670
Cardiometabolic Immunoassay	50,153		66,552
Molecular Diagnostic Solutions	45,989		60,263
Specialized Diagnostic Solutions	13,307		10,853
Total revenues	$	1,002,259	$	375,338